* Medifast Inc MED.N MED is expected to show a fall in
quarterly revenue when it reports results on May 1.
* The Owings Mills Maryland-based company is expected to
report
a 23.5% decrease in revenue to $319.517 million from $417.6
million a year ago, according to the estimate from one analyst,
based on Refinitiv data. The company's guidance on February 21
2023, for the period ended March 31, was for revenue between
$300.00 million and $320.00 million.
* Refinitiv's mean analyst estimate for Medifast Inc is for
earnings of $2.40 per share.
* The one available analyst rating on the shares is
"hold".
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Medifast
Inc is
$94, above its last closing price of $91.65.
This summary was machine generated April 28 at 22:34 GMT. All
figures in US dollars unless otherwise stated